Instem Launches In Silico Toxicology Service
Technology-enabled service delivers fast, efficient, comprehensive in silico toxicology predictions
CONSHOHOCKEN, PA – Business Wire, December 10, 2020 - Instem, a leading provider of IT solutions to the global life sciences market, announced today that it has launched the Predict™ In Silico Toxicology service. Predict™ is a leading edge, technology-enabled service that delivers a combination of powerful computation models with expert scientific review, to help clients predict chemical safety more quickly, efficiently and comprehensively.
The new service leverages Instem’s expertise in delivering technology-enabled services with computational solutions developed by Leadscope, an Instem company, who are leaders in the area of In Silico Toxicology. Known for their advanced informatics and prediction technology, together with comprehensive database solutions, Leadscope helps organizations around the world effectively unlock valuable knowledge contained in both public and proprietary sources of research data. Clients searching Leadscope’s toxicity databases can access well over 500,000 toxicology studies for more than 200,000 chemicals, enabling fast, accurate, defendable and regulatory-accepted predictions.
The new Predict™ In Silico Tox service builds on the power of these world-leading computational models and databases, combining them with expert scientific review, to deliver comprehensive, unbiased, high quality, regulatory-accepted assessments of chemical safety.
The Predict™ service is delivered by an experienced team, in conjunction with external consultants, who have a deep understanding of applicable guidelines and regulatory agencies’ processes, as well as extensive experience in computational methodologies, toxicology, and chemistry. All assessments and expert reviews are based on a documented standard operating procedure and leverage an infrastructure that ensures the latest information is being used, including historical databases of toxicity studies. The new service supports a variety of applications including the ICH M7 pharmaceutical impurities guideline, assessment of extractables and leachables, and classification and labelling.
Dr. Glenn Myatt, Instem’s Vice President of Informatics said, “We are extremely excited to launch our new Predict™ service, and we are encouraged to see our clients realizing immediate value from our service.” Dr. Myatt added “Ideal for organizations of all sizes, Predict™ has been designed to meet the needs of small and medium sized organizations that may not have the necessary team to perform an expert review, by providing a complete (Q)SAR solution to satisfy regulatory requirements. For larger organizations with in-house expertise and technology, Predict™ offers an additional option to complement their in-house capabilities or to assist during times of peak demand.”
To learn more about Predict™ download the fact sheet.
About Instem - From Concepts to Cures.
A global provider of leading software solutions and scientific insight services, Instem is helping clients bring their life enhancing products to market faster. We enable organizations in the life sciences to more efficiently collect, report and submit high quality regulatory data, while offering them the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Across the entire drug development value chain, every day Instem solutions are meeting the rapidly expanding needs of life science organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India
Marketing Manager - In Silico Solutions